GSK launched voluntary open offer at INR 3,100/share (26% premium) to raise stake in GSK Pharmaceuticals India from 50.7% to 75% — total cost ~£629M (~$1.02B).
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Financial impact
Neutral
Assessment window: 5yr post-close.
Key facts
AnnouncedDec 16, 2013
ClosedMar 21, 2014
Deal value$1.0B
Deal typeAsset Purchase
Therapeutic areaBranded prescription, India market